본문으로 건너뛰기
← 뒤로

Botulinum Toxin as a Novel Treatment for Chronic Exertional Compartment Syndrome in the U.S. Military.

Military medicine 2019 Vol.184(5-6) p. e458-e461

Hutto WM, Schroeder PB, Leggit JC

관련 도메인

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Hutto WM, Schroeder PB, Leggit JC (2019). Botulinum Toxin as a Novel Treatment for Chronic Exertional Compartment Syndrome in the U.S. Military.. Military medicine, 184(5-6), e458-e461. https://doi.org/10.1093/milmed/usy223
MLA Hutto WM, et al.. "Botulinum Toxin as a Novel Treatment for Chronic Exertional Compartment Syndrome in the U.S. Military.." Military medicine, vol. 184, no. 5-6, 2019, pp. e458-e461.
PMID 30215765

Abstract

Chronic exertional compartment syndrome (CECS) is a debilitating condition that is not uncommon in athletes and military service members. The only curative treatment for this condition, surgical fascial release, was first described in 1956. In the ensuing 62 years, this has remained the standard therapy despite symptom recurrence in 45% of military service members who underwent surgery. In 2013, a case series introduced intracompartmental injections of botulinum toxin A as a non-surgical treatment option for CECS, which proved effective in 15 out of 16 patients. In this case report, we present the case of a U.S. military service member treated with BoNT-A for bilateral lower leg CECS. This patient remains pain free at 11 months after initial treatment. This case, coupled with previously published cases series, demonstrates the potential of this novel treatment as a long-term, non-surgical alternative for CECS in the U.S. military population.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 2

MeSH Terms

Botulinum Toxins, Type A; Compartment Syndromes; Humans; Male; Military Personnel; Neurotoxins; Physical Exertion; United States; Young Adult

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문